MRTX1719 (BMS-986504)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRTX1719 (BMS-986504), covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion [Phase 1]